NOVO.B.DK

283.7

+4.34%↑

GMAB.DK

1,581.5

+3.88%↑

HLUNB.DK

44.56

+1.41%↑

ZEAL.DK

332

+10.96%↑

AMBUB.DK

66.35

+3.67%↑

NOVO.B.DK

283.7

+4.34%↑

GMAB.DK

1,581.5

+3.88%↑

HLUNB.DK

44.56

+1.41%↑

ZEAL.DK

332

+10.96%↑

AMBUB.DK

66.35

+3.67%↑

NOVO.B.DK

283.7

+4.34%↑

GMAB.DK

1,581.5

+3.88%↑

HLUNB.DK

44.56

+1.41%↑

ZEAL.DK

332

+10.96%↑

AMBUB.DK

66.35

+3.67%↑

NOVO.B.DK

283.7

+4.34%↑

GMAB.DK

1,581.5

+3.88%↑

HLUNB.DK

44.56

+1.41%↑

ZEAL.DK

332

+10.96%↑

AMBUB.DK

66.35

+3.67%↑

NOVO.B.DK

283.7

+4.34%↑

GMAB.DK

1,581.5

+3.88%↑

HLUNB.DK

44.56

+1.41%↑

ZEAL.DK

332

+10.96%↑

AMBUB.DK

66.35

+3.67%↑

Kodu・Aktsiate loetelu・Coloplast A-S (Class B)

Coloplast A-S (Class B)

Suletud

383.8 1.29

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

376.1

Max

386.1

Põhinäitajad
By Trading Economics
Sissetulek	-2.4B -971M
Müük	41M 7.1B
P/E Sektori keskmine	40.267 49.888
Aktsiakasum	-0.16
Dividenditootlus	6.02
Kasumimarginaal	-13.707
Töötajad	17,083
EBITDA	2.8B 5.1B

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+11.86% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	6.02% 2.38%

Turustatistika
By TradingEconomics
Turukapital	-5.3B 85B
Eelmine avamishind	382.51
Eelmine sulgemishind	383.8

Coloplast A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. juuni 2026, 23:22 UTC

Tulu

Suurimad hinnamuutused turgudel

Broadcom Shares Slide Despite Jump in 2Q Revenue on AI Chip Demand -- Update

3. juuni 2026, 23:09 UTC

Kuumad aktsiad

Stocks to Watch: Broadcom, CrowdStrike, PVH, Petco

3. juuni 2026, 20:51 UTC

Tulu

Costco Reports 15% Sales Growth in May

3. juuni 2026, 20:43 UTC

Tulu

Broadcom 2Q Revenue Climbs on AI Chip Demand

3. juuni 2026, 23:48 UTC

Market Talk

Nikkei May Fall Amid Renewed Concerns About Iran Conflict -- Market Talk

3. juuni 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. juuni 2026, 23:35 UTC

Market Talk

Oil Futures Fall on Possible Technical Correction -- Market Talk

3. juuni 2026, 23:15 UTC

Market Talk

Tulu

Five Below, Broadcom and Crowdstrike Fall Despite Solid Results -- Market Talk

3. juuni 2026, 22:08 UTC

Kuumad aktsiad

After-Hours Stocks to Watch: CrowdStrike, Broadcom, Five Below -- WSJ

3. juuni 2026, 21:54 UTC

Market Talk

Correction to Oil Futures Rise on Concerns About U.S.-Iran Talks Article on June 1

3. juuni 2026, 21:18 UTC

Tulu

Broadcom's Non-AI Semiconductor Revenue Rose 6% in 2Q, CEO Says

3. juuni 2026, 21:15 UTC

Tulu

Broadcom CEO: Google Partnership Continues to Be 'Very Substantial'

3. juuni 2026, 21:13 UTC

Tulu

Broadcom CEO Expects AI Semiconductor Revenue Growth to Continue in Fiscal 2028

3. juuni 2026, 21:13 UTC

Tulu

Broadcom Continues to Expect AI Semiconductor Revenue of More Than $100B in 2027, CEO Says

3. juuni 2026, 21:12 UTC

Tulu

Broadcom Expects AI Semiconductor Revenue of $56B This Year, CEO Says

3. juuni 2026, 21:09 UTC

Tulu

Broadcom CEO: Networking Made Up Almost 40% of AI Revenue in 2Q

3. juuni 2026, 21:03 UTC

Tulu

Broadcom Stock Falls After Earnings. Here's Why. -- Barrons.com

3. juuni 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3. juuni 2026, 20:43 UTC

Tulu

CrowdStrike Stock Falls Despite Earnings Beat -- Barrons.com

3. juuni 2026, 20:39 UTC

Omandamised, ülevõtmised, äriostud

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 4th Update

3. juuni 2026, 20:37 UTC

Omandamised, ülevõtmised, äriostud

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 3rd Update

3. juuni 2026, 20:35 UTC

Tulu

Broadcom Stock Falls Despite Record Results -- Barrons.com

3. juuni 2026, 20:21 UTC

Omandamised, ülevõtmised, äriostud

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 2nd Update

3. juuni 2026, 20:17 UTC

Tulu

Broadcom 2Q Semiconductor Solutions Revenue $15B >AVGO

3. juuni 2026, 20:17 UTC

Tulu

Broadcom Sees 3Q Semiconductor Revenue From AI $16B >AVGO

3. juuni 2026, 20:15 UTC

Omandamised, ülevõtmised, äriostud

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- Update

3. juuni 2026, 20:15 UTC

Tulu

Broadcom 2Q Adj EPS $2.44 >AVGO

3. juuni 2026, 20:15 UTC

Tulu

Broadcom 2Q EPS $1.91 >AVGO

3. juuni 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

3. juuni 2026, 20:15 UTC

Tulu

Broadcom 2Q Rev $22.19B >AVGO

Võrdlus sarnastega

Hinnamuutus

Coloplast A-S (Class B) Prognoos

Hinnasiht

By TipRanks

11.86% tõus

12 kuu keskmine prognoos

Keskmine 901.38 DKK 11.86%

Kõrge 1,056 DKK

Madal 720 DKK

Põhineb 8 Wall Streeti analüütiku instrumendi Coloplast A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

Osta

Hoia

Müü

Põhineb 8 analüütiku instrumendi Coloplast A-S (Class B) aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.